The global enzymes market size is estimated to be valued at USD 14.0 billion in 2024 and is projected to reach USD 20.4 billion by 2029, recording a CAGR of 7.8%. The growth of the enzymes market is fueled by key factors such as a notable surge in demand for processed foods, driven by changing consumer lifestyles and preferences. This trend necessitates the use of enzymes to improve the quality, texture, and shelf-life of these products. Enzymes find expanding applications across various industries, including pharmaceuticals, biofuels, textiles, and more, contributing to their widespread adoption and market growth.
Request Sample Pages of Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46202020
Drivers and Opportunities
Drivers: Growing environmental concerns and increasing demand for biofuel
The depletion of non-renewable resources has heightened the need for manufacturing biofuels, which have minimal environmental impact. In countries with surplus agricultural capacity, ethanol derived from biomass presents a viable alternative to traditional motor fuels like gasoline, diesel, and kerosene. This ethanol can serve as a substitute, extender, or octane booster. Biofuels are produced from agricultural waste materials such as corn stalks, leaves, sugarcane bagasse, sugar beet, sorghum stalks, wheat, barley, rye, and by-products from industries like cheese-making and potato processing. Biofuels offer a significant advantage by replacing toxic oxygenates in petroleum fuels, thus contributing to pollution reduction. The growing demand for biofuels has led to increased usage of enzymes, including amylases, lipases, cellulase, and proteases, which are essential in the biofuel production process. Among these, amylase enzymes are expected to dominate the biofuel enzymes market due to their robust performance across a wide range of temperatures and pH levels.
Opportunities: Demand for alternatives to synthetic chemicals
Enzymes are increasingly recognized as viable alternatives to traditional synthetic chemicals, offering environmentally friendly solutions to industrial challenges. Synthetic chemicals pose significant environmental threats due to their harmful nature. In contrast, enzymes like amylase and cellulase, derived from plants and microorganisms, operate under mild conditions, reducing energy consumption and greenhouse gas emissions. These enzymes are utilized in industries such as textile processing, starch processing, and biofuel production. The leather industry, for example, has adopted proteases and trypsin instead of lime and sulfides, achieving higher yields and cleaner products. Similarly, amylase and protease are employed in the bakery industry to maximize output.
The plant-derived enzymes segment holds a significant market share in the enzymes market growth
The use of amylase derived from barley and wheat in the brewing industry. Amylase is critical for breaking down starches into fermentable sugars, which improves the efficiency and quality of beer production. Additionally, pectinase, sourced from fruits like apples and oranges, is extensively used in the juice and wine industries to clarify beverages and increase juice yield. Plant enzymes also play a crucial role in the growing market for plant-based and vegan products. For instance, transglutaminase, derived from plant sources, is utilized in meat alternatives to improve texture and binding properties, addressing the increasing consumer demand for sustainable and ethical food options. This trend is supported by the rising popularity of plant-based diets, which boosts the market for plant-derived enzymes.
Buy This Report Now: https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=46202020
By specialty enzyme applications, the pharmaceuticals segment is projected to hold the highest market share during the forecast period
In drug formulation, enzymes like immobilized lipases are critical for synthesizing chiral intermediates, which are crucial in creating enantiomerically pure drugs. For example, the production of statins, widely used to lower cholesterol, relies on specialty enzymes to ensure the precise construction of their complex molecular structures.
In biopharmaceutical production, enzymes such as trypsin and pepsin are indispensable. Trypsin, specifically, is used in the manufacturing process of insulin and monoclonal antibodies. These enzymes facilitate protein cleavage and purification, ensuring the production of high-purity biopharmaceutical products. For instance, Genentech’s production of monoclonal antibodies incorporates enzymatic processing steps that are crucial for achieving therapeutic-grade purity.
Asia Pacific is poised to experience the highest CAGR in the enzymes industry during the forecast period
The region’s food and beverage sector are rapidly expanding due to rising consumer demand for processed foods and beverages. For example, the demand for convenience foods and beverages in countries like China and India is soaring, driving the need for food-processing enzymes. According to Nestlé India Annual Report, 2023, Nestlé has committed to investing USD 700 million in expanding its manufacturing capabilities to meet the rising consumer demand for processed foods.
The region’s pharmaceutical and biotechnology sectors are also expanding rapidly. According to the India Brand Equity Foundation, 2023, India’s pharmaceutical industry, which contributes over 20% of the global generics market, relies heavily on enzymes for drug production.
